Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd., established in 1970, having over 17,000 employees globally, is the largest manufacturer of antineoplastic drugs, surgical drugs and contrast media in China. Its operating income was over USD 2.4 billion in 2018. All APIs and finish dosage forms have passed national GMP authentication. APIs are approved by US-FDA, EDQM, PMDA and TGA. FDFs are approved by US-FDA, EU and PMDA.
Location: 
A16

Contact details

No. 7, Kunlunshan Road,
Economic & Technological
222047
Lianyungang
Jiangsuu
China